HHM Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.1K Buy
+1,500
New +$47.8K 0.01% 354
2024
Q3
Sell
-90
Closed -$2.11K 783
2024
Q2
$2.11K Hold
90
﹤0.01% 702
2024
Q1
$2.59K Hold
90
﹤0.01% 676
2023
Q4
$2.95K Hold
90
﹤0.01% 666
2023
Q3
$2.51K Hold
90
﹤0.01% 702
2023
Q2
$3.07K Hold
90
﹤0.01% 710
2023
Q1
$2.71K Hold
90
﹤0.01% 702
2022
Q4
$2.54K Hold
90
﹤0.01% 585
2022
Q3
$3K Hold
90
﹤0.01% 567
2022
Q2
$3K Hold
90
﹤0.01% 695
2022
Q1
$4K Hold
90
﹤0.01% 620
2021
Q4
$6K Buy
90
+40
+80% +$2.77K ﹤0.01% 555
2021
Q3
$4K Hold
50
﹤0.01% 558
2021
Q2
$5K Hold
50
﹤0.01% 523
2021
Q1
$4K Hold
50
﹤0.01% 504
2020
Q4
$5K Hold
50
﹤0.01% 459
2020
Q3
$3K Hold
50
﹤0.01% 449
2020
Q2
$3K Hold
50
﹤0.01% 432
2020
Q1
$2K Buy
+50
New +$1.67K ﹤0.01% 427

Other funds holding ARKG

HHM Wealth Advisors's ARKG Position: Q2 2026 in Review

HHM Wealth Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 1,500 shares worth $63.1K. The stake represents 0.01% of the portfolio and ranks #354 among its holdings. This is a return to the name: HHM Wealth Advisors previously reported a position in ARKG as recently as Q2 2024.

HHM Wealth Advisors first reported a position in ARKG in Q1 2020 and has held it in 19 quarters since. 41 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • HHM Wealth Advisors held 1,500 shares of ARK Genomic Revolution ETF worth $63.1K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new HHM Wealth Advisors position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #354 holding.
  • HHM Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 19 quarters since.
  • 41 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.